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ABSTRACT
Recent studies have shown that complete lymph node 
dissection (CLND) performed immediately did not 
improve the overall survival in patients with sentinel 
lymph node (LN)-positive melanoma. According to 
these results, nodal observation with ultrasonography 
becomes standard. However, it still has some limitations 
for detection of metastatic LNs. A 74-year-old woman 
was diagnosed with acral lentiginous melanoma of her 
left sole. The sentinel LN was positive for metastasis, 
but she refused CLND. Sixteen months after opera-
tion, ultrasonography showed an abnormal LN in the 
inguinal region. There was no other abnormal LNs 
around the LN. We resected the abnormal LN. The 
resected LN was black in color, and the adjacent LN 
that showed normal appearance in ultrasonography was 
also black. A recent study showed only 6.6% sensitivity 
in preoperative ultrasonographic detection of metastatic 
melanoma in a LN. We should keep in mind the limita-
tion of ultrasonography for detection of a metastatic LN.
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Recent studies have shown that complete lymph node 
dissection (CLND) performed immediately did not 
improve the overall survival in patients with sentinel 
lymph node (LN)-positive melanoma.1, 2 According 
to these results, the most standard therapeutic option 
in patients with sentinel LN-positive melanoma is 
currently nodal observation.3 In patients in whom 
immediate CLND was not performed and who were 
carefully followed up with ultrasonography and com-
puted tomography (CT), if metastasis and local and/or 
regional recurrence occur, systemic therapy or delayed 
CLND should be considered. Ultrasonography is use-
ful for detection of LN metastases and depicts their 
characteristic imaging features.4, 5 However, it still has 
some limitations for detection of metastatic LNs.
PATIENT REPORT
A 74-year-old woman was diagnosed with acral len-
tiginous melanoma of her left sole, and she underwent 
complete resection and a sentinel LN biopsy 2 years ago 
(Fig. 1a). The sentinel LN was positive for metastasis, 
but there was no evidence of distant metastasis in CT 
(T3bN1aM0, stageIIIC, tumor thickness of 3.3 mm, 
AJCC ver. 8). She refused CLND because of the risk 
for development of postoperative lymph edema and 
received adjuvant therapy with nivolumab for 1 year. 
During this therapy, we performed careful follow-up 
with physical examination, CT and ultrasonography, 
and there were no findings of LN metastases and/
or distant metastases were noted. Four months after 
finishing the adjuvant therapy, ultrasonography showed 
a round LN with 8 × 9 mm in size in the inguinal region 
and disappearance of the normal structure in the LN 
(yellow arrow in Fig. 1b). Physical examination showed 
no palpable LN in the inguinal region. The LN adjacent 
to this abnormal LN on the right side was 5 × 6 mm in 
size and had a normal shape with preservation of a nor-
mal hilus (red arrow in Fig. 1b). An increased vascular 
signature was observed for the former abnormal LN but 
not the latter. We considered that the abnormal LN was 
metastatic and performed LN biopsy. The resected LN 
was black in color and was occupied by metastatic mela-
noma cells histopathologically (yellow arrow in Fig. 1c). 
The adjacent LN that showed a normal appearance in 
ultrasonography was also black in color and exhibited 
metastatic foci of 5 mm in diameter histopathologically 
(red arrow in Figs. 1c and d). Because some intrapelvic 
lymph nodes were also slightly swollen and the patient 
refused inguinal and intrapelvic lymph node dissec-
tion, pembrolizumab was administered. Additionally, 
although she still has some swollen lymph nodes that 
have gradually enlarged, there is no distant metastasis 1 
year after starting pembrolizumab.
DISCUSSION
Recently, ultrasonography has become a standard tool 
for following up melanoma patients without immediate 
Patient ReportYonago Acta Medica 2021;64(3):315–317 doi: 10.33160/yam.2021.08.008
Corresponding author: Hiroyuki Goto, MD
higoto@tottori-u.ac.jp
Received 2021 April 9
Accepted 2021 July 16
Online published 2021 August 2
Abbreviations: CLND, complete lymph node dissection; LN, 
lymph node
316
H. Goto et al.
© 2021 Tottori University Medical Press
CLND even if the sentinel LN was positive for metas-
tasis.1, 2 This strategy is beneficial for patients because 
immediate CLND does not prolong prognosis and has 
some complications.1, 2 Therefore, the use of immediate 
CLND is limited to regional disease control. According 
to the strategy, when LN distinct metastasis is found 
during the follow-up period, we should consider delayed 
CLND. Therefore, early detection of metastasis in LNs 
is important to minimize the influence of treatment 
delay on survival.
Ultrasonography is used for evaluation of the size, 
shape and vascular signature of LNs. Several studies 
have demonstrated the usefulness of ultrasonography 
of LNs for postoperative follow-up in melanoma pa-
tients.4, 5 Massive LN metastasis can be easily detected 
by ultrasonography as shown in our case. However, a re-
cent study showed only 6.6% sensitivity in preoperative 
ultrasonographic detection of metastatic melanoma in 
an LN, emphasizing the difficulty of its detection.6 We 
should keep in mind the limitation of ultrasonography 
for detection of a metastatic LN in patients with SLN-
positive melanoma. Recently developed techniques 
including elastography may be useful for improving 
the sensitivity.7, 8 We consider that immediate CLND is 
still one of the therapeutic options in patients with SLN-
positive melanoma due to its excellent local control.1 
Local control is one of important factors for patients of 
melanoma without BRAF mutation, which is common 
in Asian and colored skin people, because therapeutic 
options are limited.9 Because we sometimes experi-
ence conflicting results with the use of sonography, we 
should carefully select therapeutic options case by case 
for patients with SNB-positive melanoma.
The authors declare no conflict of interest.
Fig. 1. (a) Primary lesion on her left sole. (b) A picture of sonography 4 months after finishing adjuvant therapy. Although the sizes of 
all lymph nodes were less than 1 cm, the left-side lymph node was round in shape and had an increased vascular signature. The right-
side lymph node had the normal lymph node structure and did not have an increased vascular signature. Arrows show the same LNs 
with the same color arrow as those in Figs. 1b and c. (c) Resected LNs with a black color (bar = 1 cm). (d) Histopathological specimen of 
the LN with a red arrow (HE staining, bar = 250 µm). HE, hematoxylin-eosin.
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